| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.019 | 42.805 | 985.894 | 791.262 | - | - | - | - | - | - |
| Total Income - EUR | 82.449 | 24.899 | 979.447 | 789.526 | - | - | - | - | - | - |
| Total Expenses - EUR | 74.244 | 52.321 | 854.889 | 770.244 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 8.204 | -27.422 | 124.558 | 19.282 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 6.892 | -27.422 | 104.652 | 11.369 | - | - | - | - | - | - |
| Employees | 0 | 0 | 4 | 6 | - | - | - | - | - | - |
Check the financial reports for the company - Bio Europalet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 124 | 591 | 13.904 | 10.121 | - | - | - | - | - | - |
| Current Assets | 101.780 | 58.823 | 235.072 | 396.231 | - | - | - | - | - | - |
| Inventories | 39.420 | 40.497 | 67.345 | 94.215 | - | - | - | - | - | - |
| Receivables | 0 | 9.085 | 98.057 | 260.152 | - | - | - | - | - | - |
| Cash | 62.360 | 9.241 | 69.669 | 23.468 | - | - | - | - | - | - |
| Shareholders Funds | 9.142 | -18.373 | 86.589 | 96.369 | - | - | - | - | - | - |
| Social Capital | 2.250 | 2.227 | 2.189 | 2.149 | - | - | - | - | - | - |
| Debts | 92.762 | 77.788 | 162.387 | 309.983 | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3832 - 3832" | |||||||||
| CAEN Financial Year |
3832
|
|||||||||
Comments - Bio Europalet Srl